FDA Adverse Event Injury Summary report: N

TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM

MDR report key: 2111807 · Received June 2, 2011

Report

Report Number
2134265-2011-01965
Event Type
Injury
Date Received
June 2, 2011
Date of Event
May 6, 2007
Report Date
May 6, 2011
Manufacturer
BOSTON SCIENTIFIC - MAPLE GROVE
Product Code
NIQ
PMA / PMN Number
P030025
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MANUFACTURER: THE COMPLAINT DEVICE WAS NOT RECEIVED AT THE COMPLAINT INVESTIGATION SITE (CIS) FOR ANALYSIS. THE BATCH NUMBER IS UNKNOWN AND THE MANUFACTURING RECORDS FOR THE COMPLAINT DEVICE COULD NOT BE REVIEWED. THE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATIONS AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED WITHIN THE DFU. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT POST A STENTING TREATMENT PROCEDURE, THROMBOSIS OCCURRED. THE PATIENT PRESENTED WITH CHEST PAIN AND AN ACUTE MYOCARDIAL INFARCTION. THE TOTALLY OCCLUDED TARGET LESION WAS LOCATED IN THE RIGHT CORONARY ARTERY (RCA). A 3.5X32MM TAXUS STENT WAS ADVANCED TO THE LESION AND DEPLOYED. POST PROCEDURE, THE PATIENT WAS ADMINISTERED PLAVIX. THREE YEARS LATER, THE PATIENT HAD IN-STENT THROMBOSIS. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND IS NOT AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TAXUS EXPRESS2 PACLITAXEL-ELUTING CORONARY STENT SYSTEM CORONARY DRUG-ELUTING STENT NIQ BOSTON SCIENTIFIC - MAPLE GROVE UNK432

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention